|
4-(2-amino-1H-imidazol-4-yl)-N-dodecyl-butyramide hydrochloride |
|
Staphylococcus |
Regulation |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-hexadecylbutanamide;hydrochloride |
Depiction based on curated SMILES
ClH
H
2
N
N
H
N
O
N
H
CH
3
|
Staphylococcus |
Regulation |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-octadecylbutanamide;hydrochloride |
Depiction based on curated SMILES
ClH
H
2
N
N
H
N
O
N
H
CH
3
|
Staphylococcus |
Regulation |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-tetradecylbutanamide;hydrochloride |
Depiction based on curated SMILES
ClH
H
2
N
N
H
N
O
N
H
CH
3
|
Staphylococcus |
Regulation |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-tridecylbutanamide;hydrochloride |
Depiction based on curated SMILES
N
H
ClH
H
2
N
N
H
N
O
CH
3
|
Acinetobacter Pseudomonas Staphylococcus |
Biofilm Biofilm Regulation |
Preclinical (in vitro) Preclinical (in vitro) Preclinical (in vivo) |
Ballard TE, et al. 2008. Chemistry
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-undecylbutanamide;hydrochloride |
Depiction based on curated SMILES
ClH
NH
2
NH
N
O
H
3
C
N
H
|
Staphylococcus |
Regulation |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
Mupirocin |
Depiction based on curated SMILES
O
O
O
HO
H
3
C
H
H
3
C
OH
H
H
H
O
H
H
3
C
O
H
H
H
HO
OH
|
Staphylococcus |
α-hemolysin |
Preclinical (in vitro) |
Jin Y, et al. 2018. Front Microbiol |
|
N-(3-(2-Aminopyrimidin-5-yl)prop-2-yn-1-yl)octanamide |
Depiction based on curated SMILES
H
2
N
N
N
CH
3
NH
O
|
Pseudomonas Staphylococcus |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Lindsey EA, et al. 2012. Org Biomol Chem
|
|
N-[3-(2-aminopyrimidin-5-yl)propyl]decanamide |
Depiction based on curated SMILES
NH
N
H
2
N
N
CH
3
O
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Lindsey EA, et al. 2012. Org Biomol Chem |
|
| | |
| | |
| | |